PBK and neoplasm: As an emerging alternative to the current cell cycle regulatory targets described above, TOPK’s chemotherapeutic potential is threefold:TOPK expression is enhanced in tumours arising from numerous histological subtypes and is suppressed in non-transformed cells from differentiated tissues.